<code id='6094131E54'></code><style id='6094131E54'></style>
    • <acronym id='6094131E54'></acronym>
      <center id='6094131E54'><center id='6094131E54'><tfoot id='6094131E54'></tfoot></center><abbr id='6094131E54'><dir id='6094131E54'><tfoot id='6094131E54'></tfoot><noframes id='6094131E54'>

    • <optgroup id='6094131E54'><strike id='6094131E54'><sup id='6094131E54'></sup></strike><code id='6094131E54'></code></optgroup>
        1. <b id='6094131E54'><label id='6094131E54'><select id='6094131E54'><dt id='6094131E54'><span id='6094131E54'></span></dt></select></label></b><u id='6094131E54'></u>
          <i id='6094131E54'><strike id='6094131E54'><tt id='6094131E54'><pre id='6094131E54'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:95
          After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

          WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

          But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

          advertisement

          The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Multiple sclerosis has subtypes with different best treatments: study
          Multiple sclerosis has subtypes with different best treatments: study

          Inanewstudyofmultiplesclerosis,patientsinoneparticularsubgrouphaddifferencesinnaturalkillercells,whi

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

          RichardDrew/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsl